BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 94 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $72,000 | -21.7% | 68,434 | +25.9% | 0.00% | -20.0% |
| Q2 2019 | $92,000 | +80.4% | 54,339 | +256.6% | 0.01% | +66.7% |
| Q1 2019 | $51,000 | +18.6% | 15,239 | +4.3% | 0.00% | 0.0% |
| Q4 2018 | $43,000 | -74.9% | 14,615 | -47.5% | 0.00% | -62.5% |
| Q3 2018 | $171,000 | -70.4% | 27,828 | -68.4% | 0.01% | -65.2% |
| Q1 2018 | $577,000 | -33.6% | 88,012 | +105.3% | 0.02% | -43.9% |
| Q4 2015 | $869,000 | +246.2% | 42,878 | +148.2% | 0.04% | +355.6% |
| Q3 2015 | $251,000 | – | 17,278 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |